Ethyl 2-((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl)amino)acetate, 95.0%, 250mg

3-Nitrophthalic anhydride, 95.0%, 10g

3-Chlorophenol, 98.0%, 100g

2-(3-(Trifluoromethoxy)phenyl)ethanol, 95.0%, 1g

1,4,7-Tri(p-tolylsulfonyl)-1,4,7-triazacyclononane, 98%, 100mg

1-TERT-BUTYL 2-METHYL 5-CYANOPYRROLIDINE-1,2-DICARBOXYLATE, 95.0%, 500mg

Evaporating flasks, 1000 ml, 29/32, 1 Piece

(1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate compound with (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclopentyl acetate, 98%, 1g

3,6-Dichloroimidazo[1,2-b]pyridazine, 95.0%, 5g

3-Bromo-5,6,7,8-tetrahydroquinoline, 95.0%, 250mg

Didecyl phthalate, 98%, 500g

(S)-2-([2,2'-Bipyridin]-6-yl)-4-phenyl-4,5-dihydrooxazole, 97%, 250mg

BENZYL 3-HYDROXYPROPYLMETHYLCARBAMATE, 95.0%, 5g